Review article: Gastric cancer and Helicobacter pylori

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 16, Issue 4, 2002, Pages 83-88

  Axon, Anthony ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ACHLORHYDRIA; AGE; ATROPHY; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BILE REFLUX; CANCER; CANCER RISK; CAUSE OF DEATH; DIET; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEREDITY; HOST; HUMAN; INTESTINE METAPLASIA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STOMACH; STOMACH CANCER; MICROBIOLOGY; STOMACH TUMOR;

ACHLORHYDRIA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; RISK FACTORS; STOMACH NEOPLASMS; HUMANS;

EID: 0036268057     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Alternative projections of mortality and disability by cause 1990-2020 - Global burden of disease study
2. Poor housing in childhood and high rates of stomach cancer in England and Wales
3. Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: Morphology, mucin histochemistry, polyamine metabolism, and labelling index
4. Bile reflux and intestinal metaplasia in gastric mucosa
5. N-nitroso compounds in fresh gastric juice and their relation to intragastric pH and nitrite employing an improved analytical method
6. Gastric cancer risk in chronic atrophic gastritis. Statistical calculations of cross-sectional data
7. Prevalence of intestinal metaplasia in Helicobacter pylori gastritis
8. Recent advances in gastritis
9. Intestinal metaplasia and Helicobacter pylori in patients with non-ulcer dyspepsia. More arguments for the natural history
10. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection
11. Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H. pylori
12. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
13. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease
14. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts
15. Most gastric cancer occurs on the distal side of the endoscopic atrophic border
16. An international association between Helicobacter pylori infection and gastric cancer
17. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults
18. Helicobacter pylori infection and the development of gastric cancer
19. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer
20. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils
21. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy
22. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: Relation to gastric mucosal ascorbic acid concentrations and effect of H. pylori eradication
23. Ascorbic acid in the human stomach
24. The effect of cimetidine on the gastric bacterial flora
25. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa